Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ: VNDA · Real-Time Price · USD
4.240
+0.020 (0.47%)
At close: Oct 15, 2026, 4:00 PM EDT
4.260
+0.020 (0.47%)
After-hours: Oct 15, 2026, 7:40 PM EDT
Vanda Pharmaceuticals Market Cap
Vanda Pharmaceuticals has a market cap or net worth of $256.36 million as of October 15, 2026. It is the 19,332nd most valuable company in the world and the 3,353rd biggest in the United States. Its market cap has decreased by 17.04% in one year.
Market Cap
256.36M
Enterprise Value
109.16M
1-Year Change
-17.04%
Global Rank
Country Rank
#3,353 United States
Category
ChartMarket Cap Chart
Since April 12, 2006, Vanda Pharmaceuticals's market cap has increased from $209.50M to $256.36M, an increase of 22.37%. That is a compound annual growth rate of 0.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 256.36M | -50.81% |
| Dec 31, 2025 | 521.20M | 86.61% |
| Dec 31, 2024 | 279.30M | 15.03% |
| Dec 29, 2023 | 242.80M | -41.94% |
| Dec 30, 2022 | 418.20M | -52.16% |
| Dec 31, 2021 | 874.10M | 21.64% |
| Dec 31, 2020 | 718.60M | -17.90% |
| Dec 31, 2019 | 875.30M | -36.13% |
| Dec 31, 2018 | 1.37B | 100.69% |
| Dec 29, 2017 | 682.90M | -2.57% |
| Dec 30, 2016 | 700.90M | 75.84% |
| Dec 31, 2015 | 398.60M | -17.90% |
| Dec 31, 2014 | 485.50M | 17.87% |
| Dec 31, 2013 | 411.90M | 294.54% |
| Dec 31, 2012 | 104.40M | -21.97% |
| Dec 30, 2011 | 133.80M | -49.57% |
| Dec 31, 2010 | 265.30M | -13.30% |
| Dec 31, 2009 | 306.00M | 2,200.75% |
| Dec 31, 2008 | 13.30M | -92.75% |
| Dec 31, 2007 | 183.40M | -66.04% |
| Dec 29, 2006 | 540.00M | 157.76% |
| Apr 12, 2006 | 209.50M | - |
View and export this data all the way back to 2006. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| EyePoint | 286.22M |
| Fulcrum Therapeutics | 286.11M |
| Abeona Therapeutics | 280.20M |
| X4 Pharmaceuticals | 279.59M |
| Palisade Bio | 277.09M |
| Nautilus Biotechnology | 276.14M |
| Clinuvel Pharmaceuticals | 272.74M |
| Rocket Pharmaceuticals | 272.24M |